Alnylam PharmaceuticalsALNY 
$243.250.41%24h
0.41%24h
Global rank568
Market cap$30.38B
Change 7d-4.75%
YTD Performance-
SP500 benchmark
P/E-69.11
P/S16.62
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals (ALNY) Net Assets
ALNY Net Assets in 2024: $-220.64M
As of 14 Jan 2025, Alnylam Pharmaceuticals net assets is $-220.64M, an increase of 39.45% to 2023. Net assets are calculated as total assets minus total liabilities. This value represents the Alnylam Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Alnylam Pharmaceuticals Net Assets History from 2018 to 2025
-
Value:-
ALNY Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $-220.64M | 39.45% |
| 2022 | $-158.22M | -126.90% |
| 2021 | $588.20M | -42.12% |
| 2020 | $1.02B | -29.36% |
| 2019 | $1.44B | -150.07% |
| 2018 | $-2.87B | - |
View the Top Net Assets Companies
